📺 Novozymes will absorb smaller domestic rival Chr. Hansen. The 38% premium dwarfs expected synergies. And Novo Holdings, the main shareholder of both groups, will retain majority voting rights. pierrebri has more
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Danish $22 bln enzyme M&A is costly bet on growthNovozymes will absorb smaller domestic rival Chr. Hansen. The 38% premium dwarfs expected synergies from the deal. And Novo Holdings, the biggest shareholder in both groups, will retain majority voting rights. Novozymes investors look to be paying too much for future growth.
続きを読む »
Happy Homecoming: Chicago native returns as star of Tony Award-winning 'Dear Evan Hansen'Chicago native Anthony Norman returns to his hometown a star, the star of the North American tour of 'Dear Evan Hansen,' the Tony Award-winning tuner about a socially awkward teen who inadvertently becomes a social media sensation.
続きを読む »
American-made products come from these small businesses in time for the holidaysThree small business owners joined the 'Fox & Friends Weekend' crew on Saturday to showcase their American-made products that make strong gifts for the Christmas and holiday season.
続きを読む »